Ronak Jalali

Ronak Jalali

Auto-generated profile, based on publicly available information

Ronak Jalali

School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Journal of Orthopaedic Surgery
Verified
Journal Article
Open access
YMYashar Mashayekhi
Yashar Mashayekhi
AAAmir-Mohammad Asgari
Amir-Mohammad Asgari
MFMohammad Taha Pahlevan Fallahy
Mohammad Taha Pahlevan Fallahy
MKMohammad Amin Karimi
Mohammad Amin Karimi
RJRonak Jalali
Ronak Jalali
FSFarhad Shaker
Farhad Shaker
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for obesity and type 2 diabetes mellitus (T2DM). While their metabolic benefits are well-established, their impact on postoperative outcomes following total joint arthroplasty (TJA) remains controversial. This study aimed to systematically evaluate the association between GLP-1 RA use and postoperative outcomes in patients undergoing total hip (THA), knee (TKA), or shoulder arthroplasty (TSA). Methods: We conducted a PRISMA-compliant systematic review and meta-analysis across PubMed, Embase, Web of Science, and Scopus through April 24, 2025. Eligible retrospective cohort studies compared adults undergoing TJA with and without preoperative GLP-1 RA exposure. Primary outcomes were 90-day readmission and all-cause revision. Pooled odds ratios (ORs) and standardized mean differences (SMDs) were calculated under random-effects models. Subgroup analysis based on the type of arthroplasty was conducted where applicable. Results: Fourteen studies (total sample size of 365,154; including 62,117 (17.01%) GLP-1 consumers, and 303,037 (82.98%) control cases) met the inclusion criteria (All studies included primary TJA cases). GLP-1 RA use was associated with lower 90-day readmission (OR = 0.86, 95% CI: 0.74-0.99, p = 0.033) and reduced sepsis incidence (OR = 0.63, 95% CI: 0.46–0.88, p = 0.006). No significant differences were observed for all-cause revision, thromboembolic events, and other medical and surgical complications. Length of stay was marginally shorter in GLP-1 users (SMD = −0.09, p = 0.048). Subgroup analyses showed the strongest sepsis reduction in TSA. Conclusion: GLP-1 RA use before TJA is associated with reduced readmission and sepsis risk without increasing surgical or thromboembolic complications. These findings support the potential perioperative benefits of GLP-1 RAs, warranting prospective trials to confirm causality and define optimal perioperative strategies for high-risk arthroplasty patients.

1 October 2025 in JBJS Open Access
Verified
Journal Article
Open access
MFMohammad Taha Pahlevan Fallahy
Mohammad Taha Pahlevan Fallahy
FSFarhad Shaker
Farhad Shaker
AAAmir-Mohammad Asgari
Amir-Mohammad Asgari
SBSadra Behrouzieh
Sadra Behrouzieh
RJRonak Jalali
Ronak Jalali
SSSourena Sharifkashani
Sourena Sharifkashani
Background: Inflammatory Bowel Disease (IBD) is associated with systemic inflammation and which might influence surgical outcomes. As total joint arthroplasty (TJA) becomes increasingly common in this population as they age, this study aimed to evaluate whether IBD is associated with increased postoperative complications following total hip or knee arthroplasty. Methods: We performed a systematic review of studies including patients with and without IBD undergoing TJA. Databases searched included PubMed, Scopus, Web of Science, and Embase through February 24, 2025. Eligible studies included adults with a confirmed diagnosis of IBD who underwent TJA. Meta-analyses were conducted using random-effects models with 95% confidence intervals. Results: Fourteen studies comprising 2,651,318 patients (86,581 with IBD) met inclusion criteria. IBD was significantly associated with increased risks of PJI (OR: 1.47), hospital readmission (OR: 1.39), pneumonia (OR: 1.92), PTE (OR: 1.61), VTE (OR: 1.59), DVT (OR: 1.60), ileus (OR: 5.7), C. difficile infection (OR: 3.3), MI (OR: 2.12), CVA (OR: 2.90), UTI (OR: 2.31), sepsis (OR: 1.83), respiratory failure (OR: 2.17), revision surgery (OR: 1.38), periprosthetic fracture (OR: 1.82), wound (OR: 1.52) and implant complications (OR: 1.62). Length of hospital stay was marginally longer (SMD: 0.06). Mortality and non-home discharge did not differ significantly between groups. Conclusion: Patients with IBD undergoing TJA are at an elevated risk for some postoperative complications, especially infections, thromboembolic events, and revision surgeries. These findings support personalized management strategies in this population. Level of Evidence: Level IIIa. See Instructions for Authors for a complete description of levels of evidence.

10 September 2026 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
FSFarhad Shaker
Farhad Shaker
AAAmir-Mohammad Asgari
Amir-Mohammad Asgari
MKMohammad Amin Karimi
Mohammad Amin Karimi
RJRonak Jalali
Ronak Jalali
FBFarnam Behroo
Farnam Behroo
MFMohammad Taha Pahlevan Fallahy
Mohammad Taha Pahlevan Fallahy
While hypoalbuminemia is recognized as a risk factor for adverse postoperative outcomes in various surgeries, its specific impact on spinal fusion outcomes

18 December 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
YMYashar Mashayekhi
Yashar Mashayekhi
AAAmir-Mohammad Asgari
Amir-Mohammad Asgari
MFMohammad Taha Pahlevan Fallahy
Mohammad Taha Pahlevan Fallahy
RJRonak Jalali
Ronak Jalali
SBSara Baba-Aissa
Sara Baba-Aissa
FSFarhad Shaker
Farhad Shaker
Background: Crystallopathies, including gout and calcium pyrophosphate deposition (CPPD), are prevalent conditions that complicate total joint arthroplasty (TJA). This study aims to evaluate the impact of crystallopathy on postoperative outcomes following total hip and knee arthroplasty, including complication rates, revision risks, and functional recovery. Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA 2020 guidelines. Studies comparing the outcomes in adult patients undergoing total hip or knee arthroplasty between cases with and without crystallopathy were included. A random-effects meta-analysis was performed using R software version 4.4.2. Sensitivity and subgroup analyses were conducted to identify outliers and assess effect sizes based on crystallopathy type and arthroplasty type. Results: A total of 23 267 319 TJA cases, including 921 787 crystallopathy group cases, were analyzed. The meta-analysis revealed a significantly higher rate of wound complications (OR = 1.41, 95% CI: 1.03–1.91), prosthetic joint infection (PJI) (OR = 1.97, 95% CI: 1.01–3.83), thromboembolic events (OR = 1.19, 95% CI: 1.06–1.33), and non-home discharge rates (OR = 1.20, 95% CI: 1.02–1.40) in the crystallopathy group, all of which lost significance in sensitivity analysis. However, no significant differences were observed in in-hospital mortality, transfusion needs, myocardial infarction (MI), revision surgery, length of stay (LOS), hospital charges, and emergency department (ED) visits. Conclusion: Patients with crystallopathies might be at an increased risk of wound complications, PJI, thromboembolic events, and non-home discharge. These findings emphasize the importance of preoperative risk assessment and personalized perioperative management for this patient group.